A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy

Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock

(2013) Sheryl Zelenitsky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

(2012) S. J. van Hal et al.   CLINICAL INFECTIOUS DISEASES

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy

(2012) Darren M. Roberts et al.   CRITICAL CARE MEDICINE

Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients

(2012) Eva Ocampos-Martinez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Augmented renal clearance in septic patients and implications for vancomycin optimisation

(2012) João Pedro Baptista et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Analysis of Pathogen and Host Factors Related to Clinical Outcomes in Patients with Hospital-Acquired Pneumonia Due to Methicillin-Resistant Staphylococcus aureus

(2012) N. Z. Haque et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?

(2012) Bruno Van Herendael et al.   Annals of Intensive Care

Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens

(2011) Jason A. Roberts et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy

(2011) Deborah A. Pasko et al.   BLOOD PURIFICATION

Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

(2011) Marta Ulldemolins et al.   CHEST

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)

(2011) F. Perry Wilson et al.   CLINICAL NEPHROLOGY

Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients

(2011) Weerachai Chaijamorn et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study

(2011) Håkan Hanberger et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock

(2011) M. Vázquez et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis

(2011) M. A. Cataldo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA Pneumonia

(2009) Y. Harigaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections

(2009) Karine Berthoin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS